STORY FROM: Drugs & Medical Devices

Torrent Expands Recall of Losartan Drugs, Citing NMBA Contamination

WASHINGTON, D.C. — India-based drug maker Torrent Pharmaceuticals Ltd. has further expanded its voluntary recall of losartan-containing drugs to include 114 additional lots due to unacceptable amounts of N-Methylnitrosobutyric acid (NMBA), according to the Food and Drug Administration.

A March 4 FDA alert says NMBA, a potential human carcinogen, was reportedly found in an active pharmaceutical ingredient manufactured by Hetero Labs Ltd., also based in India.

Torrent and Hetero are only recalling lots of losartan-containing medication with NMBA above the interim acceptable intake limits of 0.96 parts per million, the FDA says.

The agency emphasized that drugs containing only amlodipine ...



Registered User Login

Username

Password

True